Dipeptidyl peptidase inhibitors for treating diabetis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/513 (2006.01) A61K 31/131 (2006.01) A61K 31/44 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2622608

Pharmaceutical compositions comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4- dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and pharmaceutically acceptable salts thereof are provided as well as kits and articles of manufacture comprising the pharmaceutical compositions as well as methods of using the pharmaceutical compositions.

La présente invention porte sur des compositions pharmaceutiques renfermant du 2-[[6-[(3R)-3-amino-1-pipéridinyl]-3,4-dihydro-3-méthyl-2,4-dioxo-1(2H)-pyrimidinyl]méthyl]-benzonitrile et des sels pharmaceutiquement acceptables de ce composé, sur des trousses et des articles manufacturés comprenant ces compositions pharmaceutiques, ainsi que sur des procédés d'utilisation de ces compositions pharmaceutiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dipeptidyl peptidase inhibitors for treating diabetis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dipeptidyl peptidase inhibitors for treating diabetis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dipeptidyl peptidase inhibitors for treating diabetis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1362250

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.